Pet Vaccine Market Size was valued at USD 11.7 Bn in 2024 and is predicted to reach USD 23.1 Bn by 2034 at a 7.4% CAGR during the forecast period for 2025-2034.
Pet vaccines encompass the creation, production, and distribution of vaccines intended to prevent the emergence of particular infectious illnesses in pets, with a focus on pets of all kinds. The growing number of pets, better understanding of pet health, and advancements in veterinary science have all contributed to this market's growth. Vaccine administration technological developments are also fueling market expansion. Vaccination procedures are becoming easier and more efficient because of innovations like oral vaccinations and needle-free vaccine administration devices.
Pets with needle fear or challenges to handle will especially benefit from these developments. Pet owners may now more easily obtain these necessary items thanks to the growing availability of vaccinations through various distribution methods, including internet platforms. The increasing popularity of pet insurance, which frequently pays for vaccinations, is another element pushing pet proprietors to vaccinate their animals regularly and propelling market expansion.
However, the strict legal framework controlling the creation and authorization of vaccines for livestock is one of the main obstacles. Regulatory procedures are frequently drawn out to guarantee both the security and effectiveness of vaccinations and require substantial expenditures in clinical investigations and research. This may raise the total expense of manufacturing and postpone the release of prospective vaccines into the marketplace. Additionally, especially in areas with smaller spending on healthcare and smaller financial resources, the high expense of vaccinations can be a significant barrier.
• Bayer AG
• Elanco US Inc.
• Merck KGaA
• Merial Inc.
• Virbac SA
• Zoetis Inc
• Phibro Animal Health Corporation
• Boehringer Ingelheim GmbH
• Tianjin Ringpu Bio-Technology Co., Ltd
• Vetoquinol SA
• Others
The pet vaccine market is segmented based on animal type, vaccine type, and mode of administration. Based on the animal type, the market is segmented into canine, feline, and equine.. The market is segmented by vaccine type into modified/ attenuated live, inactivated (killed), and others. By mode of administration, the market is segmented into injectable vaccines, intranasal Vaccines and others.
Canine is expected to hold a major global market share in 2024 in the pet vaccine market because of their overwhelming numbers and intimate interpersonal relationships. With rigorous vaccination requirements for illnesses including rabies, parvovirus illness, and canine pneumonia, canines are among the most common pets in the world. Their vulnerability to several zoonotic infections highlights the public health importance of canine immunization. Additionally, continuous improvements in the study of canine vaccines, such as customized ones, keep spurring innovation and market expansion.
The injectable vaccine segment is growing in the pet vaccine market because it is simple to administer, has an established reputation, and is efficient. Furthermore, injectable vaccinations are convenient for pet proprietors and veterinarian clinics due to their simplicity of carrying and storing. They maintain to rule the pet vaccine industry because they provide a tried-and-true approach to protecting companion animals' health.
The North American pet vaccine market is expected to register the highest market share in revenue in the near future. This can be attributed to the region's substantial ownership of animal paces, sophisticated veterinary treatment facilities, and the robust presence of major industries. Pet owners are very conscious of the value of immunizations, and the United States has widely recognized veterinary healthcare facilities.
The major driver includes pet humanity and the corresponding increase in spending on pet wellness. In addition, the Asia Pacific is expected to grow rapidly in the pet vaccine market due to the expanding adoption of animals, increasing financial resources, and greater knowledge of pet hygiene. The need for pet vaccinations in this area is anticipated to be driven by the expanding pet adoption trend and the increased emphasis on preventative healthcare.
• In September 2024, Bayer declared its firm had secured a unique permit for an innovative biology pesticide by signing a deal with AlphaBio Command, a UK-based company. The newly developed good is expected to be the initial for crops, such as grains and oilseed rape, to be made affordable. This new pesticide was found by AlphaBio, for which Bayer distributes FLiPPER, a successful bioinsecticide-acaricide. Its initial launch is scheduled to take place, assuming further investigation and authorization.
• In October 2024, Merck and Gilead Sciences, Inc. revealed the findings of the second section of the research program assessing a mixture of lenacapavir, a first-in-class HIV-1 infection capstone preventive and islatravir, an investigational amino acid transcription migration drug.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 11.7 Billion |
|
Revenue Forecast In 2034 |
USD 23.1 Billion |
|
Growth Rate CAGR |
CAGR of 7.4% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Animal Type, By Vaccine Type, By Mode of Administration and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Bayer AG, Elanco US Inc., Merck KGaA, Merial Inc., Virbac SA, Zoetis Inc, Phibro Animal Health Corporation, Boehringer Ingelheim GmbH, Tianjin Ringpu Bio-Technology Co., Ltd, and Vetoquinol SA. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pet Vaccine Market Snapshot
Chapter 4. Global Pet Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Pet Vaccine Market Industry Trends
4.10. Global Pet Vaccine Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Pet Vaccine Market Segmentation 1: By Animal Type, Estimates & Trend Analysis
5.1. Market Share By Animal Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Canine
5.2.2. Feline
5.2.3. Equine
Chapter 6. Pet Vaccine Market Segmentation 2: By Vaccination, Estimates & Trend Analysis
6.1. Market Share By Vaccination, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
6.2.1. Canine Family
6.2.2. Feline Family
6.2.3. Others
Chapter 7. Pet Vaccine Market Segmentation 3: By Mode Of Administration, Estimates & Trend Analysis
7.1. Market Share By Mode Of Administration, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
7.2.1. Injectable Vaccines
7.2.2. Intranasal Vaccines
Chapter 8. Pet Vaccine Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Pet Vaccine Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.2.3. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.2.4. North America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.3. Europe
8.3.1. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.3.3. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.3.4. Europe Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.4.3. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.4.4. Asia Pacific Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.5. Latin America
8.5.1. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.5.3. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.5.4. Latin America Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Animal Type, 2021-2034
8.6.3. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Vaccination, 2021-2034
8.6.4. Middle East & Africa Pet Vaccine Market Revenue (US$ Million) Estimates and Forecasts By Mode Of Administration, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Elanco US Inc.
9.2.3. Merck KGaA
9.2.4. Merial Inc.
9.2.5. Virbac SA
9.2.6. Zoetis Inc
9.2.7. Phibro Animal Health Corporation
9.2.8. Boehringer Ingelheim GmbH
9.2.9. Tianjin Ringpu Bio-Technology Co., Ltd
9.2.10. Vetoquinol SA
Pet Vaccine Market-By Animal Type
• Canine
• Feline
• Equine
Pet Vaccine Market-By Vaccine Type
• Modified/ Attenuated Live
• Inactivated (Killed)
• Other Vaccines
Pet Vaccine Market-By Mode of Administration
• Injectable Vaccines
• Intranasal Vaccines
• Others
Pet Vaccine Market-By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
